Technology · 14/10/2026

EMA Grants Waiver for Tevimbra, a Cancer Treatment for All Age Groups

The European Medicines Agency (EMA) has granted a waiver for Tevimbra, a treatment for various cancers, allowing its use in all age groups without a pediatric investigation plan. This decision was made under the Paediatric Investigation Plan (PIP) process.